Seegene Completes IPO, Raises $16.6M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Korean molecular diagnostics firm Seegene today said it has raised $16.6 million in its initial public offering.

The company said it had sold 636,500 shares of its stock on the KOSDAQ (Korea Securities Dealers Automated Quotations) at KRW30,500 ($26.16) per share, and now has a market capitalization of $167 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.